tetano
Editor, Senior Moderator
J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25825. [Epub ahead of print]
The Presence of SARS-CoV-2 RNA in Feces of COVID-19 Patients.
Chen Y[SUP]1[/SUP], Chen L[SUP]2[/SUP], Deng Q[SUP]2[/SUP], Zhang G[SUP]1[/SUP], Wu K[SUP]1[/SUP], Ni L[SUP]1[/SUP], Yang Y[SUP]1[/SUP], Liu B[SUP]1[/SUP], Wang W[SUP]1[/SUP], Wei C[SUP]1[/SUP], Yang J[SUP]1[/SUP], Ye G[SUP]2[/SUP], Cheng Z[SUP]1[/SUP].
Author information
Abstract
BACKGROUND:
In December 2019, Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), emerged in Wuhan, China, and has spread globally. However, the transmission route of SARS-CoV-2 has not been fully understood. In this study, we aimed to investigate the SARS-CoV-2 shedding in excreta of COVID-19 patients.
METHODS:
Electronical medical records, including demographics, clinical characteristics, laboratory and radiological findings, of enrolled patients were extracted and analyzed. Pharyngeal swab, stool and urine specimens were collected and tested for SARS-CoV-2 RNA by RT-PCR. Viral shedding at multiple time points in specimens was recorded, and analyzed its correlation with clinical manifestations and the severity of illness.
RESULTS:
A total of 42 laboratory-confirmed patients were enrolled, 8 (19.05%) of whom had gastrointestinal symptoms. 28 (66.67%) patients tested positive for SARS-CoV-2 RNA in stool specimens, which was not associated with the presence of gastrointestinal symptoms and the severity of illness. Among them, 18 (64.29%) patients remained positive for viral RNA in feces after pharyngeal swabs turned negative. The duration of viral shedding from feces after negative conversion in pharyngeal swabs was 7 (6-10) days, regardless of COVID-19 severity. The demographics, clinical characteristics, laboratory and radiologic findings did no differ between patients tested positive and negative for SARS-CoV-2 RNA in feces. Viral RNA was not detectable in urine specimens from 10 patients.
CONCLUSIONS:
Our results demonstrated the presence of SARS-CoV-2 RNA in feces of COVID-19 patients, and suggested the possibility of SARS-CoV-2 transmission via the fecal-oral route. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
KEYWORDS:
Coronavirus Disease 2019; Fecal-oral transmission; Severe Acute Respiratory Syndrome Coronavirus 2; Viral RNA; Viral shedding
PMID:32243607DOI:10.1002/jmv.25825
The Presence of SARS-CoV-2 RNA in Feces of COVID-19 Patients.
Chen Y[SUP]1[/SUP], Chen L[SUP]2[/SUP], Deng Q[SUP]2[/SUP], Zhang G[SUP]1[/SUP], Wu K[SUP]1[/SUP], Ni L[SUP]1[/SUP], Yang Y[SUP]1[/SUP], Liu B[SUP]1[/SUP], Wang W[SUP]1[/SUP], Wei C[SUP]1[/SUP], Yang J[SUP]1[/SUP], Ye G[SUP]2[/SUP], Cheng Z[SUP]1[/SUP].
Author information
Abstract
BACKGROUND:
In December 2019, Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), emerged in Wuhan, China, and has spread globally. However, the transmission route of SARS-CoV-2 has not been fully understood. In this study, we aimed to investigate the SARS-CoV-2 shedding in excreta of COVID-19 patients.
METHODS:
Electronical medical records, including demographics, clinical characteristics, laboratory and radiological findings, of enrolled patients were extracted and analyzed. Pharyngeal swab, stool and urine specimens were collected and tested for SARS-CoV-2 RNA by RT-PCR. Viral shedding at multiple time points in specimens was recorded, and analyzed its correlation with clinical manifestations and the severity of illness.
RESULTS:
A total of 42 laboratory-confirmed patients were enrolled, 8 (19.05%) of whom had gastrointestinal symptoms. 28 (66.67%) patients tested positive for SARS-CoV-2 RNA in stool specimens, which was not associated with the presence of gastrointestinal symptoms and the severity of illness. Among them, 18 (64.29%) patients remained positive for viral RNA in feces after pharyngeal swabs turned negative. The duration of viral shedding from feces after negative conversion in pharyngeal swabs was 7 (6-10) days, regardless of COVID-19 severity. The demographics, clinical characteristics, laboratory and radiologic findings did no differ between patients tested positive and negative for SARS-CoV-2 RNA in feces. Viral RNA was not detectable in urine specimens from 10 patients.
CONCLUSIONS:
Our results demonstrated the presence of SARS-CoV-2 RNA in feces of COVID-19 patients, and suggested the possibility of SARS-CoV-2 transmission via the fecal-oral route. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
KEYWORDS:
Coronavirus Disease 2019; Fecal-oral transmission; Severe Acute Respiratory Syndrome Coronavirus 2; Viral RNA; Viral shedding
PMID:32243607DOI:10.1002/jmv.25825
